Chondroitin Joint Pain Randomized Trial Evidence Table

Structured evidence table for Chondroitin Joint Pain Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.

topicclaimevidence levelcitationsource
Chondroitin Joint Pain Randomized TrialOsteoarthritis (OA) is prevalent in the Indian subcontinent and Southeast Asia, causing pain, reduced mobility, and disability.4Prabhoo R (2026)Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
Chondroitin Joint Pain Randomized TrialAn evidence-based analysis showed that undenatured type II collagen (40 mg/day) improves pain, stiffness, function, and quality of life in early-to-moderate OA (Grades 1-3), with benefits observed within eight weeks, improved compliance, and non-steroidal anti-inflammatory drug-sparing effects.4Prabhoo R (2026)Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
Chondroitin Joint Pain Randomized TrialComparative evidence favors UC-II® (Lonza Greenwood LLC, USA) over other sources, highlighting the importance of product selection.4Prabhoo R (2026)Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
Chondroitin Joint Pain Randomized TrialGenetic, lifestyle, and comorbidity factors contribute to earlier onset and more severe disease than in Western populations.4Prabhoo R (2026)Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
Chondroitin Joint Pain Randomized Triallonga extract produced a significant reduction in pain and clinical signs associated with OA.4Tripathi SD (2026)Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.
Chondroitin Joint Pain Randomized TrialIntroduction Osteoarthritis (OA) is a progressive degenerative joint disease characterized by cartilage deterioration, leading to chronic pain and impaired immobility particularly in older dogs.4Tripathi SD (2026)Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.
Chondroitin Joint Pain Randomized TrialAim This study investigated the protective effects of a turmerosaccharides-rich extract of Curcuma longa L.4Tripathi SD (2026)Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.
topicChondroitin Joint Pain Randomized Trial
claimOsteoarthritis (OA) is prevalent in the Indian subcontinent and Southeast Asia, causing pain, reduced mobility, and disability.
evidence level4
citationPrabhoo R (2026)
sourceEvidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
topicChondroitin Joint Pain Randomized Trial
claimAn evidence-based analysis showed that undenatured type II collagen (40 mg/day) improves pain, stiffness, function, and quality of life in early-to-moderate OA (Grades 1-3), with benefits observed within eight weeks, improved compliance, and non-steroidal anti-inflammatory drug-sparing effects.
evidence level4
citationPrabhoo R (2026)
sourceEvidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
topicChondroitin Joint Pain Randomized Trial
claimComparative evidence favors UC-II® (Lonza Greenwood LLC, USA) over other sources, highlighting the importance of product selection.
evidence level4
citationPrabhoo R (2026)
sourceEvidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
topicChondroitin Joint Pain Randomized Trial
claimGenetic, lifestyle, and comorbidity factors contribute to earlier onset and more severe disease than in Western populations.
evidence level4
citationPrabhoo R (2026)
sourceEvidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
topicChondroitin Joint Pain Randomized Trial
claimlonga extract produced a significant reduction in pain and clinical signs associated with OA.
evidence level4
citationTripathi SD (2026)
sourceProtective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.
topicChondroitin Joint Pain Randomized Trial
claimIntroduction Osteoarthritis (OA) is a progressive degenerative joint disease characterized by cartilage deterioration, leading to chronic pain and impaired immobility particularly in older dogs.
evidence level4
citationTripathi SD (2026)
sourceProtective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.
topicChondroitin Joint Pain Randomized Trial
claimAim This study investigated the protective effects of a turmerosaccharides-rich extract of Curcuma longa L.
evidence level4
citationTripathi SD (2026)
sourceProtective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.

Source documents

  1. Evidence-Based Use of Undenatured Type II Collagen in the Management of Osteoarthritis in the Indian Subcontinent and Southeast Asia: A Narrative Review and an Expert Opinion.
  2. Protective effects of turmerosaccharides rich extract of <i>Curcuma longa</i> L. in osteoarthritic dogs.